Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Todd Neale

November 08, 2016

Presentation TCT 2016

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Neil E. Moat, John G. Webb, Marina Urena

October 31, 2016

News Daily News

ICD and Pacemaker Needs After Open Heart Surgery: Series Provides a Benchmark

Todd Neale

October 21, 2016

Presentation TVT 2016

Conduction Disturbances and Arrhythmias After TAVR: Remaining Issues and Best Clinical Practices

Presenter: Josep Rodés-Cabau

June 17, 2016

Presentation TVT 2016

Can CT Imaging Help to Characterize High-Risk Patients for Conduction Disturbances During TAVR?

Presenter: Jonathon A. Leipsic

June 16, 2016

Presentation TVT 2016

Incidence and Clinical Impact of Atrial Fibrillation in TAVR Patients

Presenter: Philippe Généreux

June 16, 2016

Presentation TVT 2016

Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Azeem Latib

June 16, 2016

Presentation TVT 2016

Evolving Trends in the Incidence and Importance of Conduction Disturbances After TAVR

Presenter: Tamim Nazif

June 16, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Daily News

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

Michael O'Riordan

May 02, 2016

Presentation TCT 2015

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Isaac George, Augusto D. Pichard, Susheel Kodali

October 15, 2015

Presentation TVT 2015

Prevention and Management of Conduction Disturbances and Arrhythmias (AF) After TAVR

Presenter: Tamim Nazif

June 05, 2015

Presentation TVT 2015

Incidence and Prognostic Impact of Conduction Disturbances and Arrhythmias (AF) After TAVR

Presenter: Josep Rodés-Cabau

June 05, 2015

News Industry News

Medtronic CoreValve® Evolut(TM) R System Yields Exceptional Outcomes in First Clinical Study

March 16, 2015

Presentation TCT 2014

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Tamim Nazif

September 14, 2014

News Daily News

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Yael L. Maxwell

July 10, 2014

News Daily News

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

May 07, 2014

News Daily News

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Jason Kahn

January 16, 2014

Presentation TCTAP 2013

Can We Prevent Conduction Disturbances?

Presenter: Corrado Tamburino

April 25, 2013

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

Advertisement

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

ICD and Pacemaker Needs After Open Heart Surgery: Series Provides a Benchmark

Conduction Disturbances and Arrhythmias After TAVR: Remaining Issues and Best Clinical Practices

Can CT Imaging Help to Characterize High-Risk Patients for Conduction Disturbances During TAVR?

Incidence and Clinical Impact of Atrial Fibrillation in TAVR Patients

Clinical Implications of New LBBB and New Pacemakers After TAVR

Evolving Trends in the Incidence and Importance of Conduction Disturbances After TAVR

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Prevention and Management of Conduction Disturbances and Arrhythmias (AF) After TAVR

Incidence and Prognostic Impact of Conduction Disturbances and Arrhythmias (AF) After TAVR

Medtronic CoreValve® Evolut(TM) R System Yields Exceptional Outcomes in First Clinical Study

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Patient Traits Predict Need for Permanent Pacemaker After TAVR

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Can We Prevent Conduction Disturbances?

Review of TAVR Use Offers Significant Advances, Positive Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content